Market news

Shares of healthcare services company Astrana Health fell 5.5% in the afternoon session after the company disclosed a "material" cybersecurity incident and data breach at its subsidiary, Astrana Health Management.

Astrana Health (ASTH) said in a regulatory filing Wednesday that certain confidential information ma

Astrana Health is scaling as a cash-generative, value-based care platform with accelerating revenue and improving margins. Read why ASTH stock is a Buy.

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here. The strategy returned 24.01% in the second quarter, outperforming the Russell 2000 Index’s 21.49% return. Performance was positively affected by stock selection in health care and industrials, while the Fund’s underweight […]

Astrana Health’s second quarter was met with a positive market response, as management highlighted several drivers behind the results. The company saw continued demand from payer and provider partners, maturation of value-based care cohorts, and disciplined medical cost trend management. CEO Brandon Sim attributed operating leverage improvements to the company’s proprietary AI-native healthcare operating system, which has enabled more efficient workflows and reduced general and administrative ex

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

Astrana Health (ASTH) buy thesis: 46% peer discount, Care Enablement margins, capitation-led growth, and $48 PT (+28%).

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +29.03% and -0.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Healthcare services company Astrana Health fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next quarter’s revenue guidance of $1.02 billion underwhelmed, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $0.80 per share was 9.6% above analysts’ consensus estimates.

Astrana Health (ASTH) Q2 Earnings: What To Expect

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

Astrana Health stock has surged 86.5% year to date, yet the company still carries a low overall value score and screens as expensive on traditional valuation multiples, which raises the question of how much of the recent optimism is already reflected in the price. The 86.5% year to date gain points to strong momentum, but also means new buyers are paying a much higher entry price than they could earlier in the year. Recent shared savings performance and revenue growth can support high...